| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0.1B | $0.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.3B | $1.2B | $1.2B | $1.1B | $0.9B | $0.6B | $0.2B | $0.2B |
| EPS (Basic) | $9.58 | $8.39 | $8.23 | $7.98 | $6.16 | $3.99 | $1.29 | $1.19 |
| EPS (Diluted) | $9.52 | $8.33 | $8.18 | $7.92 | $6.10 | $3.97 | $1.29 | $1.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $80.4B | $76.0B | $69.6B | $64.1B | $60.9B | $52.2B | $44.2B | $41.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $4.2B | $5.3B | $4.6B | $3.5B | $3.9B | $4.0B | $3.3B | $3.0B |
| Total Liabilities | $71.5B | $68.3B | $62.7B | $58.1B | $55.0B | $46.9B | $39.2B | $36.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.9B | $7.7B | $7.0B | $6.0B | $5.8B | $5.3B | $5.0B | $4.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.4B | $1.4B | $2.1B | $1.2B | $0.7B | $0.7B | $0.9B |
| Investing Cash Flow | $-5.5B | $-6.3B | $-4.2B | $-4.6B | $-9.1B | $-6.8B | $-2.6B | $-3.8B |
| Capital Expenditures | — | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $2.9B | $5.5B | $4.0B | $2.1B | $7.8B | $6.9B | $2.1B | $3.8B |